Press Room

Find out the latest news from the Alliance and the field of aging research. Media members can call 202.370.7852 or email for more information and to schedule interviews. Download our online press kit here.

The Alliance and more than 30 other organizations sent a sign-on letter urging U.S. Senate leadership "to support, and build upon, existing state Medicaid expansion."

ACT-AD Coalition Hosts Its Eighth Annual Meeting

Site Includes Data on Cancer, Diabetes, Heart Disease, Vision Loss, and More

Tweets Do Tell: Alzhemier's Not a High Priority for Research Funding

Type: Aging Today

Author: Cynthia Bens, VP of Public Policy

Date: May 13th, 2013

An article by Cynthia Bens, Alliance vice president of public policy

Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) coalition released a statement in response to guidance from the U.S. Food and Drug Administration (FDA) on the development of drugs for Alzheimer’s Disease.

Ready for Prime Time

Type: The Scientist

Author: Dennis J. Selkoe and John C. Morris

Date: February 1st, 2012

Thought Experiment: Biomarkers of Alzheimer’s disease are ready for widespread use in clinical trials.

Use biomarkers in Alzheimer's disease clinical trials, says expert group.

The Alliance for Aging Research has added new members to its Science Advisory Board including a prominent bioethicist, a world-renowned neurologist, a Nobel Prize winner in economics, a leading longevity researcher, and the only cardiologist to receive all four major cardiovascular research awards.

Sue Peschin, a leading advocate for public policies supporting Alzheimer’s disease research and services for affected families, will join the Alliance for Aging Research beginning January 2012.

Alliance Releases Latest Volume of The Silver Book Highlighting the Growing Burden of Neurological Disease and the Value of Medical Innovation

Downloadable "pocket" films help increase public understanding of a 21st century epidemic.

November is National Alzheimer's Disease Awareness Month.

First Major Survey of Baby Boomer Attitudes on Alzheimer's Shows Fear About Their Own Future and Frustration Over Pace of New Drug Approvals

Alliance for Aging Research almanac underscores human and economic impact of chronic diseases on our aging nation.